WO2007017550A1 - Clústeres cuánticos atómicos estables, su procedimiento de obtención y uso de los mismos - Google Patents
Clústeres cuánticos atómicos estables, su procedimiento de obtención y uso de los mismos Download PDFInfo
- Publication number
- WO2007017550A1 WO2007017550A1 PCT/ES2006/070121 ES2006070121W WO2007017550A1 WO 2007017550 A1 WO2007017550 A1 WO 2007017550A1 ES 2006070121 W ES2006070121 W ES 2006070121W WO 2007017550 A1 WO2007017550 A1 WO 2007017550A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- aqcs
- clusters
- atoms
- metal
- reaction
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title description 5
- 229910052751 metal Inorganic materials 0.000 claims abstract description 45
- 239000002184 metal Substances 0.000 claims abstract description 41
- 238000000034 method Methods 0.000 claims abstract description 39
- 239000012429 reaction media Substances 0.000 claims abstract description 15
- 230000001085 cytostatic effect Effects 0.000 claims abstract description 11
- 239000000824 cytostatic agent Substances 0.000 claims abstract description 6
- 230000005291 magnetic effect Effects 0.000 claims abstract description 6
- 230000001472 cytotoxic effect Effects 0.000 claims abstract description 4
- 239000010411 electrocatalyst Substances 0.000 claims abstract description 4
- 231100000433 cytotoxic Toxicity 0.000 claims abstract description 3
- 238000006722 reduction reaction Methods 0.000 claims description 20
- 230000009467 reduction Effects 0.000 claims description 18
- 239000003153 chemical reaction reagent Substances 0.000 claims description 15
- 239000003638 chemical reducing agent Substances 0.000 claims description 14
- 238000007254 oxidation reaction Methods 0.000 claims description 12
- 238000001556 precipitation Methods 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 150000003839 salts Chemical class 0.000 claims description 11
- 239000003599 detergent Substances 0.000 claims description 10
- 229910052737 gold Inorganic materials 0.000 claims description 10
- 150000002894 organic compounds Chemical class 0.000 claims description 10
- 230000003647 oxidation Effects 0.000 claims description 10
- 229910052709 silver Inorganic materials 0.000 claims description 10
- 239000003381 stabilizer Substances 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 9
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 7
- 150000002500 ions Chemical class 0.000 claims description 7
- 239000001301 oxygen Substances 0.000 claims description 7
- 229910052760 oxygen Inorganic materials 0.000 claims description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 6
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 6
- 150000001412 amines Chemical class 0.000 claims description 6
- 230000002051 biphasic effect Effects 0.000 claims description 6
- 150000002739 metals Chemical class 0.000 claims description 6
- 238000000926 separation method Methods 0.000 claims description 6
- 150000003573 thiols Chemical class 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 5
- 150000001298 alcohols Chemical class 0.000 claims description 5
- 229910052697 platinum Inorganic materials 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 150000003568 thioethers Chemical class 0.000 claims description 5
- 229910052802 copper Inorganic materials 0.000 claims description 4
- 229910052748 manganese Inorganic materials 0.000 claims description 4
- 229920000642 polymer Polymers 0.000 claims description 4
- 229920006395 saturated elastomer Polymers 0.000 claims description 4
- 238000011282 treatment Methods 0.000 claims description 4
- KWSLGOVYXMQPPX-UHFFFAOYSA-N 5-[3-(trifluoromethyl)phenyl]-2h-tetrazole Chemical compound FC(F)(F)C1=CC=CC(C2=NNN=N2)=C1 KWSLGOVYXMQPPX-UHFFFAOYSA-N 0.000 claims description 3
- 150000007513 acids Chemical class 0.000 claims description 3
- 150000002430 hydrocarbons Chemical class 0.000 claims description 3
- 229910001379 sodium hypophosphite Inorganic materials 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 2
- 125000002091 cationic group Chemical group 0.000 claims description 2
- 125000003636 chemical group Chemical group 0.000 claims description 2
- 229910052804 chromium Inorganic materials 0.000 claims description 2
- 125000004122 cyclic group Chemical group 0.000 claims description 2
- 229930195733 hydrocarbon Natural products 0.000 claims description 2
- 229910052742 iron Inorganic materials 0.000 claims description 2
- 229910052745 lead Inorganic materials 0.000 claims description 2
- 229910052759 nickel Inorganic materials 0.000 claims description 2
- 150000007524 organic acids Chemical class 0.000 claims description 2
- 235000005985 organic acids Nutrition 0.000 claims description 2
- 229910052763 palladium Inorganic materials 0.000 claims description 2
- 150000003003 phosphines Chemical class 0.000 claims description 2
- 230000005855 radiation Effects 0.000 claims description 2
- 229910052703 rhodium Inorganic materials 0.000 claims description 2
- 235000000346 sugar Nutrition 0.000 claims description 2
- 150000008163 sugars Chemical class 0.000 claims description 2
- 238000002604 ultrasonography Methods 0.000 claims description 2
- 125000000524 functional group Chemical group 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 150000001336 alkenes Chemical class 0.000 claims 1
- 150000001345 alkine derivatives Chemical class 0.000 claims 1
- 125000000129 anionic group Chemical group 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000002265 redox agent Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 abstract description 6
- 239000000376 reactant Substances 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 description 49
- 239000010931 gold Substances 0.000 description 32
- 230000015572 biosynthetic process Effects 0.000 description 31
- 238000006243 chemical reaction Methods 0.000 description 26
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 20
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 230000000694 effects Effects 0.000 description 17
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
- 239000002245 particle Substances 0.000 description 15
- 239000000243 solution Substances 0.000 description 13
- 229910021645 metal ion Inorganic materials 0.000 description 11
- 239000007864 aqueous solution Substances 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 8
- 239000004530 micro-emulsion Substances 0.000 description 8
- 239000002105 nanoparticle Substances 0.000 description 8
- RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 7
- 230000007423 decrease Effects 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 238000001493 electron microscopy Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 description 5
- JVSWJIKNEAIKJW-UHFFFAOYSA-N dimethyl-hexane Natural products CCCCCC(C)C JVSWJIKNEAIKJW-UHFFFAOYSA-N 0.000 description 5
- 239000007769 metal material Substances 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 5
- -1 AQC metals Chemical class 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 239000003792 electrolyte Substances 0.000 description 4
- 229910021397 glassy carbon Inorganic materials 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 4
- 229950010131 puromycin Drugs 0.000 description 4
- MCZDHTKJGDCTAE-UHFFFAOYSA-M tetrabutylazanium;acetate Chemical compound CC([O-])=O.CCCC[N+](CCCC)(CCCC)CCCC MCZDHTKJGDCTAE-UHFFFAOYSA-M 0.000 description 4
- 101710134784 Agnoprotein Proteins 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 238000002484 cyclic voltammetry Methods 0.000 description 3
- 238000007306 functionalization reaction Methods 0.000 description 3
- 238000005304 joining Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 238000005381 potential energy Methods 0.000 description 3
- 239000004065 semiconductor Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 239000012295 chemical reaction liquid Substances 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 239000002923 metal particle Substances 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 125000000962 organic group Chemical group 0.000 description 2
- 230000005298 paramagnetic effect Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000002096 quantum dot Substances 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000004627 transmission electron microscopy Methods 0.000 description 2
- 238000004832 voltammetry Methods 0.000 description 2
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- WDEHKPUUQDUYGZ-UHFFFAOYSA-N 2-methyl-1,3-thiazole 2H-tetrazole Chemical compound C=1N=NNN=1.CC1=NC=CS1 WDEHKPUUQDUYGZ-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 238000001069 Raman spectroscopy Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000011797 cavity material Substances 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000013626 chemical specie Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000002848 electrochemical method Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 238000002189 fluorescence spectrum Methods 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 150000002343 gold Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 229910021432 inorganic complex Inorganic materials 0.000 description 1
- 239000012212 insulator Substances 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000004502 linear sweep voltammetry Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000006911 nucleation Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 238000004313 potentiometry Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000010944 silver (metal) Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- DIORMHZUUKOISG-UHFFFAOYSA-N sulfoformic acid Chemical class OC(=O)S(O)(=O)=O DIORMHZUUKOISG-UHFFFAOYSA-N 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- VLCQZHSMCYCDJL-UHFFFAOYSA-N tribenuron methyl Chemical class COC(=O)C1=CC=CC=C1S(=O)(=O)NC(=O)N(C)C1=NC(C)=NC(OC)=N1 VLCQZHSMCYCDJL-UHFFFAOYSA-N 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
- B22F1/07—Metallic powder characterised by particles having a nanoscale microstructure
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
- B82B1/00—Nanostructures formed by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/28—Mercury; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
- B22F1/05—Metallic powder characterised by the size or surface area of the particles
- B22F1/054—Nanosized particles
- B22F1/0545—Dispersions or suspensions of nanosized particles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F9/00—Making metallic powder or suspensions thereof
- B22F9/16—Making metallic powder or suspensions thereof using chemical processes
- B22F9/18—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds
- B22F9/24—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds starting from liquid metal compounds, e.g. solutions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
- B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- C—CHEMISTRY; METALLURGY
- C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
- C25C—PROCESSES FOR THE ELECTROLYTIC PRODUCTION, RECOVERY OR REFINING OF METALS; APPARATUS THEREFOR
- C25C1/00—Electrolytic production, recovery or refining of metals by electrolysis of solutions
- C25C1/12—Electrolytic production, recovery or refining of metals by electrolysis of solutions of copper
-
- C—CHEMISTRY; METALLURGY
- C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
- C25C—PROCESSES FOR THE ELECTROLYTIC PRODUCTION, RECOVERY OR REFINING OF METALS; APPARATUS THEREFOR
- C25C1/00—Electrolytic production, recovery or refining of metals by electrolysis of solutions
- C25C1/20—Electrolytic production, recovery or refining of metals by electrolysis of solutions of noble metals
-
- C—CHEMISTRY; METALLURGY
- C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
- C25C—PROCESSES FOR THE ELECTROLYTIC PRODUCTION, RECOVERY OR REFINING OF METALS; APPARATUS THEREFOR
- C25C5/00—Electrolytic production, recovery or refining of metal powders or porous metal masses
- C25C5/02—Electrolytic production, recovery or refining of metal powders or porous metal masses from solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/241—Lead; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/242—Gold; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F2998/00—Supplementary information concerning processes or compositions relating to powder metallurgy
Definitions
- the present invention relates to new quantum clusters of atoms (AQCs) of metallic elements, characterized by being stable in solution, a method for obtaining them by kinetic control of the reaction and the uses of said AQCs as sensors (fluorescent, magnetic or chemical), electrocatalysts and as cytostatic and / or cytotoxic.
- AQCs quantum clusters of atoms
- quantum dots quantum dots
- the nucleation-growth theory is a classical thermodynamic theory that is based on the fact that the formation of a new phase (solid in this case) within a liquid (the initial solution with the reagents) always involves the appearance of an interface and, therefore, an additional interfacial energy (called Laplace energy) is required, given by the product of the interfacial tension of the solid that is formed by the interfacial area formed.
- Laplace energy an additional interfacial energy
- This energy means that particles that are smaller than a critical size are not stable and redissolve in the reaction medium. According to this theory, only particles larger than the critical size are capable of growing and forming the solid particles that are finally obtained.
- thermodynamic reasoning is valid in certain circumstances, mainly for the preparation of metal particles of sizes greater than 1-5 nm, however, this approach is not suitable for the preparation of AQCs or atomic clusters, since that in this case it does not make sense to talk about classical thermodynamic concepts such as: Laplace pressure, critical core, etc., so it does not make sense to talk about redisolution of clusters of sizes smaller than a critical one.
- the method object of the present invention has as an objective the production of stable, functionalized and controlled size AQCs (quantum clusters of atoms of metallic elements) in an easy and quantitative way, so that scaling for industrial production is easy and possible of this type of nano / subnano-materials.
- AQC nano / sub-nanometer particles formed by metallic elements
- isolated and stable atomic quantum clusters are provided, characterized by being composed of less than 500 metal atoms (Mn, n ⁇ 500, size ⁇ 2 nm), preferably composite AQCs for less than 200 metal atoms (Mn, n ⁇ 200, size ⁇ 1.9 nm), more preferably AQCs of sizes smaller than 1 nm, even more preferably between more than 2 and less than 27 metal atoms (Mn, 2 ⁇ n ⁇ 27, that is between about 0.4nm and 0.9nm in size) and even more preferably AQCs formed from 2 to 5 metal atoms and more specifically 2 or 3 atoms (corresponding to a size between 0.4 and 0.5 nm).
- AQCs formed from 2 to 5 metal atoms and more specifically 2 or 3 atoms (corresponding to a size between 0.4 and 0.5 nm).
- stable AQCs are understood as those groupings of atoms that retain the number of atoms over time and, therefore, their properties, so that they can be isolated and manipulated like any chemical compound.
- the metals from which these AQCs are formed are selected from Au, Ag, Co, Cu, Pt, Fe, Cr, Pd, Ni, Rh, Pb or its bi and multimetallic combinations.
- the AQC metals are selected from Au and Ag or their bimetallic combinations, due to the spectacular properties of some specific clusters of these metals, among which we can mention: catalysis, cytostatic properties, etc. to which reference will be made later.
- a process for the preparation of the AQCs described above consists in the reduction of the metal salt or ion (or metal salts or ions), and is characterized by a kinetic control so that the reduction of the metal salt or ion (metal salts or ions) is slowly produced, while simultaneously maintaining a Small speed constant and a low concentration of reagents.
- low concentration and small speed constant are understood as those values that lead to the system through the minimum potential energy of the corresponding reaction coordinate.
- concentrations of the metal ion and / or reducer lower than a concentration of 10 "3 M; and by speed constants smaller than those corresponding to half-reaction life times older than
- the procedure consists, as a minimum, of the following steps: a. a kinetic control for slow reduction, and b. maintain a low concentration of reagents in the reaction medium.
- the methods of preparing clusters / nanoparticles are based on the nucleation-growth theory. According to this theory, it is necessary that the reaction of production of nanoparticles / clusters be very rapid in order to achieve a large number of nuclei. Once the nucleation is produced, the nuclei all grow in unison and in this way, nanoparticles of very monodispersed sizes are obtained.
- thermodynamic theory of nucleation-growth has been very successful in explaining the preparation of monodisperse particles of micro and sub-micrometer sizes, however, the question is raised as to the extent to which the formation of a 3 or 4 atomic quantum cluster atoms by chemical reaction in solution (for example, by reduction of a salt of the corresponding metal ion by means of a reducer) can be considered as a new phase.
- the formation of a metallic cluster of a few atoms by chemical reaction in solution is more similar to the innumerable examples that exist of formation of inorganic / organometallic chemical complexes (or also to the formation of polymers) from their reagents and
- the inorganic complex or the polymer, provided that its molecular weight is not too high
- the formation of a new compound is determined by the kinetics of the process of obtaining it. And this is precisely the basis on which the procedure proposed in the present invention is based: the use of kinetic control for the production of AQCs (atomic quantum clusters) of controlled size.
- Figure 1 shows a representative scheme of the variation of free energy that is put into play throughout a reaction of formation of metals in solution, from their metal ions.
- the reagents represent any metal ion in the presence of a reducer (or a cathode where the corresponding metal ion reduction takes place).
- the reaction begins with the formation of an AQC of 1 atom (Mi), after two (M 2 ), etc. until finally solid particles of the reduced metallic material (P) are formed.
- the figure represents the fact that as the AQC grows and approaches the size of a particle, P, (it is considered a particle when the number of atoms in the atomic cluster is high, of the order of n greater than approximately 500 atoms (n> approx.
- the energy differences between different AQCs is smaller. It is noteworthy that the scheme is very general and does not indicate the fact generally found in the practice that the potential valleys may be different (eg smaller for a smaller cluster than a larger one), as well as that the activation energies may vary from one cluster to another.
- clusters is not limited to the type of metallic element synthesized or to the electrochemical method itself, so that any other chemical method of reduction of metallic salts in solution can be used for the production of these atomic clusters, as long as the reaction slow down sufficiently - as will be specified later - to observe the evolution of the AQCs and stop the reaction (eg by cooling, dilution and / or fixing / separating the clusters of the reaction medium) at the time of interest.
- AQC of a certain size.
- biphasic / bicomponent systems water / organic compound
- biphasic / tricomponents such as microemulsions formed by water, organic compound and a detergent
- a very small concentration of reagents can be available in Ia
- Water interface / organic compound are especially suitable for the preparation of clusters in macroscopic quantities suitable for scaling industrial production. This can be understood qualitatively assuming that a reaction is as if a wheel slides along the potential energy curve represented in Figure 1.
- the energy communicated to said wheel is so large that it exceeds the maximum that is between the different valleys and ends up falling to the deepest valleys (that is, quickly transforming into large P particles size -more than 2-5 nm-).
- the present invention based on slowing the reaction involves communicating a very small energy to the wheel. This, therefore, will initially fall into the first minimum (cluster Mi) and only after an appreciable time will it fall successively into the following minimums corresponding to higher AQCs. That time / times it takes for the AQC to fall into the different minima can be optimized to allow time to separate the AQCs obtained (eg by precipitation) or to stabilize them by introducing a chemical agent or stabilized molecule into the reaction medium. .
- the initial introduction into the reaction medium of stabilizing agents may vary the minimum of the potential valley of some AQC / s. Its initial introduction can therefore be carried out to favor a certain type of AQCs and also to have more time for the manipulation of the AQC before its definitive stabilization and functionalization. In any case, its introduction is not essential for the method we propose here and which we continue to describe below.
- a preferred embodiment of the present invention to slow down the reaction, is to use a mild reducer, which is selected from the group comprising sodium hypophosphite, amines, sugars, organic acids, polymers (such as polyvinylpyrrolidone), radiation UV-VIS, ultrasound or electric current.
- a mild reducer which is selected from the group comprising sodium hypophosphite, amines, sugars, organic acids, polymers (such as polyvinylpyrrolidone), radiation UV-VIS, ultrasound or electric current.
- the preferable way to proceed is to generate the metal ion "in situ" at very low concentrations by means of the anodic dissolution (preferably at a constant current) of an electrode of the corresponding metal.
- the second option is to use a two-phase system (water / organic compound) in which the metal salt dissolves in the water and a reducer is chosen that only dissolves in the organic compound (for example, but not limited to, an amine, a thiol or a long hydrocarbon chain acid), so that the reaction only occurs at the interface and, therefore, with a very small effective local concentration of reagents.
- a reducer for example, but not limited to, an amine, a thiol or a long hydrocarbon chain acid
- saturated and unsaturated, cyclic, linear or branched hydrocarbons are used as organic compounds, such as, for example, but not limited to, hexane, heptane, isooctane, cyclohexane; as well as benzene or toluene.
- the organic water-compound interface in order to increase the yield of the reaction, can be increased using microemulsions formed by water, organic compound and a detergent that allow at the same time to maintain the local concentration of Very low reagents within the nanogotas that form the microemulsion.
- anionic detergents such as aliphatic or aromatic sulphonates, for example those derived from sulfocarboxylic acids, could be used as a detergent; cationic detergents such as bromide or alkylammonium acetates; or non-ionic detergents such as polyoxyethylene derivatives.
- the evolution of the clusters can be followed and, once the cluster of the desired size has been reached, it can be protected / stabilized in the reaction medium by adding a stabilizing agent, which consists of a molecule that contains organic groups (such as thiols, sulfides, amines, acids, thioethers, phosphines or amino acids, etc.) according to the metal from which the cluster is to be obtained.
- a stabilizing agent which consists of a molecule that contains organic groups (such as thiols, sulfides, amines, acids, thioethers, phosphines or amino acids, etc.) according to the metal from which the cluster is to be obtained.
- the separation of the cluster from the reaction medium can be done by precipitation by lowering the temperature and / or adding a solvent incompatible with the cluster taking advantage of the different solubility properties that the AQCs have according to their size, as well as by fixing them taking advantage of their different affinity for The stabilizer groups mentioned.
- the functionalized AQC could be obtained.
- the stabilizing agent must be a molecule that must have at least two ends with different chemical groups: one end with one of the groups already mentioned to join the AQC and another with any other organic group (among We can cite: double and triple bonds, alcoholic groups, acid groups or amine groups) for their interaction or subsequent binding to other molecules or atoms for specific applications
- functionalized AQCs can be prepared by adding dodecanothiol dissolved in pentane, observing the transfer of the clusters of the acetonitrile phase to the pentane phase.
- a water soluble thiol or thioether such as glutathione, thioglycol, thioacetic, etc. It also allows its functionalization and transfer to water, and an additional reaction can then be used to bind the thus functionalized AQCs to any other molecule, ion or substrate for the required final applications of the AQCs.
- the use of the AQCs described above, as electrocatalysts is described.
- These clusters are very stable electrochemically so that the range of potentials of work with dispersions of these clusters is limited by the values of the reduction and oxidation potentials of the medium in which they are dispersed.
- the stability of Ag clusters in TBAAc in the interval (-3.V to + 1.8V) has been verified.
- Their high electrochemical stability makes them suitable for applications in various types of electrocatalysis reactions.
- the AQCs have their electrocatalytic activity in reduction reactions, which include, among others, the reduction of oxygen and / or Ia of hydrogen peroxide.
- reduction reactions include, among others, the reduction of oxygen and / or Ia of hydrogen peroxide.
- Stable dispersions of Ag, Au, Pt, Cu clusters that have catalytic properties have been synthesized. These properties arise as a result of the enormous reducing power that metal clusters of a few M n atoms possess (n ⁇ 50-100).
- the silver and gold clusters are capable of adsorbing oxygen gas contributing to the dissociation of the molecule and, consequently, lowering the energy necessary for its electroreduction. In example 3 this fact is widely verified.
- the AQCs exhibit their electrocatalytic activity in alcohol oxidation reactions.
- Another aspect of the present invention provides the use of the AQCs described above for the preparation of anticancer drugs for their cytostatic and / or cytotoxic properties.
- FIGURE 1 A first figure.
- Figure 1 shows a representative scheme of the variation of free energy that is put into play throughout a reaction of formation of metals in solution, from their metal ions.
- the reagents represent any metal ion in the presence of a reducer (or a cathode where the corresponding metal ion reduction takes place).
- Mi refers to an AQC of 1 atom, M 2 of two, etc.
- P refers to the solid particles of the reduced metallic material.
- FIGURE 2 shows the characteristic spectrum of Au AQCs obtained by precipitation and stabilized with dodecanothiol.
- Figure 3 shows a transmission electron microscopy of synthesized Au AQCs clusters. It should be noted that the sizes observed by microscopy (very polydispersed and larger than approx. 1-2 nm) do not really correspond to Au particles but to clusters of AQCs.
- FIGURE 4 shows a transmission electron microscopy of synthesized Au AQCs clusters. It should be noted that the sizes observed by microscopy (very polydispersed and larger than approx. 1-2 nm) do not really correspond to Au particles but to clusters of AQCs.
- FIGURE 4 shows a transmission electron microscopy of synthesized Au AQCs clusters. It should be noted that the sizes observed by microscopy (very polydispersed and larger than approx. 1-2 nm) do not really correspond to Au particles but to clusters of AQCs.
- FIGURE 4 shows a transmission electron microscopy of synthesized Au AQCs clusters.
- Figure 4 shows the measurements made by mass spectrometry by flight time.
- FIGURE 5 shows the UV-VIS spectrum of larger AQCs, both those initially dispersed in the reaction liquid, and those obtained by precipitation, protected by dodecanothiol, and redispersed again in chloroform.
- FIGURE 6 Figure 6 shows an electron microscopy photograph of the mixtures of AQCs of AUi 2 and Au 2 I, which are formed by joining 4 and 7 Au 3 clusters.
- Figure 7 shows the UV-VIS spectrum of Ag AQCs synthesized according to example 2.
- Figure 8 shows an electron microscopy photograph of the Ag AQCs synthesized according to example 2.
- FIGURE 9 This Figure shows the UV-Vis spectrum of AQCS of Ag after 5 days after the synthesis.
- FIGURE 1 1 shows the UV-Vis spectrum of Ag AQCs after 13 days after the synthesis.
- This Figure shows an electron microscopy photograph of the sample of Ag AQCs after 13 days after the synthesis.
- NP 0.1 and NP 0.2 shows the absorbance (proportional to the concentration of cells) as a function of the concentration of Ag clusters added.
- the absorbance corresponding to the cells without treatment is shown as a reference.
- the results are compared with the effect of pure solvent and puromycin.
- the different bars show the results obtained at a different number of hours (O, 24 and 48 hours).
- NP 45 and NP 46 shows the absorbance (proportional to the concentration of cells) as a function of the concentration of added Au clusters.
- the absorbance corresponding to the cells without treatment is shown as a reference.
- the results are compared with the effect of pure solvent and puromycin.
- the different bars show the results obtained at a different number of hours (O, 24 and 48 hours).
- Au the metal from which the AQCs were formed
- -Electrolytic dissolution and stabilizing agent 0.1 M in tetrabutyl ammonium bromide in acetonitrile.
- Functionalized AQCs were prepared by adding dodecanothiol dissolved in pentane, observing the transfer of the clusters of the acetonitrile phase (which became transparent) to the pentane phase (which turned yellow).
- Figure 2 shows the characteristic spectrum of Au AQCs obtained by precipitation and stabilized with dodecanothiol.
- Figure 3 shows a transmission electron microscopy of synthesized Au AQCs clusters. It should be noted that the sizes observed by microscopy (very polydispersed and larger than approx. 1-2 nm) do not really correspond to Au particles but to clusters of AQCs. The small size of these makes its direct observation by electron microscopy not possible and its presence can only be observed by the appearance of a black cloud as the background of the microscope grid, together with the formation of clusters (clusters) of these AQCs of very different sizes that are observed as blacker areas in the grid. The fact that the darkest areas do not correspond to particles, is also corroborated by the absence of the plasmonic band that should be visible in the case that they were not clusters of AQCs but particles of nanometric sizes.
- this cluster is an Au 3 indicates that the initially obtained clusters (brown), precursors of the present AQC of 3 atoms, are formed by 2 atoms. It is noted that, even unprotected, these 2 atom clusters (Au 2 ) are stable in the reaction medium for approximately 2 hours. That time would be sufficient for its precipitation, isolation and subsequent protection and / or functionalization.
- the unprotected Au 3 AQCs (in the absence of thiol) were stable under those conditions for several months. After 5 months the evolution of these AQCs was observed towards the formation of other larger AQCs, easily observable by the color change from yellow to red to the naked eye. These new larger AQCs precipitated (due to their lower solubility, since this decreases as the size of the AQC increases, due to the decrease in the entropy of the mixture). Precipitation can also be favored by decreasing the temperature. Thus, for example, the formation of an appreciable red precipitate was observed from an aliquot of the AQCs dissolution at 0-C.
- Figure 5 shows the UV-VIS spectrum of these last larger AQCs, both those initially dispersed in the reaction liquid, and those obtained by precipitation, protected by dodecanothiol, and redispersed again in chloroform.
- the new bands that appear at 410 nm and 520 nm are indicative of the existence of mixtures of AQCs of AUi 2 and Au 2 i, which are formed by joining 4 and 7 clusters of Au 3 , respectively.
- Figure 6 shows a photograph of electron microscopy of these AQCs. Again, due to their small size, only a blackish background is observed, as well as in some parts darker spots of different sizes from the formation of denser clusters of these AQCs.
- the values of the experimental parameters indicated in this example are only indicative, by way of from example.
- Other values of current densities, elements used for the cathode, temperatures and types and concentrations of the background electrolyte, as well as protective agent can also be used for the same purpose provided that a sufficiently small concentration of metal ions is maintained in the medium reaction so that the reaction passes through the minimum potential energy.
- the synthesis was carried out by mixing two microemulsions, one with the reducer and another with the silver salt.
- the silver salt microemulsion was prepared by adding 0.54 mL of the aqueous solution of AgNO 3 to that of AOT in isooctane, while that of the reducer was obtained by adding 0.54 mL of the aqueous solution of the sodium hypophosphite reducer to AOT Ia in isooctane.
- the addition of the AgNO 3 microemulsion on the reducing microemulsion was carried out keeping the drip constant for 50 minutes.
- the mixture had a yellow color that acquires greater intensity with the passage of time becoming blackish due to an increase in the concentration of the
- FIG. 8 shows a photograph of electron microscopy of Ag's AQCs. Again, it is the same as with Au's AQCs: only a grayish spot is observed to which some clusters of said AQCs are superimposed.
- the AQCs thus obtained evolved after several hours with the formation of a new cluster of 4 atoms associated with the presence of a band located around 260 nm.
- Figure 1 1 shows a photograph of the latter AQCs that, as can be seen, are still much smaller than 1 nm, so they can only be seen as a gray spot on The grid in which they were deposited.
- Au's AQCs if they were not stabilized and / or separated (eg by precipitation), the AQCs continued to grow, reaching successively larger sizes.
- the size of nanoparticles was reached, clusters larger than approx. 500 atoms, finally observing the appearance of the plasmonic band that indicated the disappearance of quantum effects of size and the formation of particles larger than approx. 1-2 nm.
- clusters formed by bi or multimetallic combinations are obtained depending on the number and concentration of the metal ions used.
- Electrocatalytic activity of metal clusters in the reduction of oxygen is Electrocatalytic activity of metal clusters in the reduction of oxygen.
- the electrocatalytic activity of the metal clusters was checked by comparing the voltammetric response in the reduction of oxygen.
- TBAAc tetrabutyl ammonium acetate
- Electrocatalytic activity of metal clusters in the reduction of hydrogen peroxide, H 2 O 2 has been verified by making measurements in free solutions of O 2 containing H 2 O 2 as the only species susceptible to reduction.
- Figure 13 shows linear sweep voltammetries in aqueous solution of H 2 O 2 containing 0.024M and 0.5M H CIO 4.
- vitreous carbon curve a
- Pt wire was used as a counter electrode. The potentials are referred to the Ag / CIAg electrode (saturated).
- Electrocatalytic activity of metal clusters in the oxidation of alcohols is Electrocatalytic activity of metal clusters in the oxidation of alcohols.
- the electrocatalytic activity of the metal clusters in the oxidation of alcohols was verified, and more specifically the use of Ag clusters in the oxidation of methanol. Said oxidation occurs in the range of OV to +1 V. To verify this effect, the Ag clusters, dispersed in acetonitrile, were deposited on polycrystalline Pt.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Inorganic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Crystallography & Structural Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials Engineering (AREA)
- Dispersion Chemistry (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Electrochemistry (AREA)
- Metallurgy (AREA)
- Manufacturing & Machinery (AREA)
- Physics & Mathematics (AREA)
- Composite Materials (AREA)
- General Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Manufacture Of Metal Powder And Suspensions Thereof (AREA)
- Powder Metallurgy (AREA)
- Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020137030859A KR101424943B1 (ko) | 2005-08-03 | 2006-07-28 | 안정한 원자 양자 클러스터, 그 제조방법 및 용도 |
JP2008524535A JP6186103B2 (ja) | 2005-08-03 | 2006-07-28 | 原子量子クラスター、その製造方法およびその使用方法 |
KR1020087005221A KR101361266B1 (ko) | 2005-08-03 | 2006-07-28 | 안정한 원자 양자 클러스터, 그 제조방법 및 용도 |
EP06778474.4A EP1914196B1 (en) | 2005-08-03 | 2006-07-28 | Stable atomic quantum clusters, production method thereof and use of same |
ES06778474T ES2799308T3 (es) | 2005-08-03 | 2006-07-28 | Clústeres cuánticos atómicos estables, su método de obtención y uso de los mismos |
US11/997,859 US9421610B2 (en) | 2005-08-03 | 2006-07-28 | Stable atomic quantum clusters, production method thereof and use of same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ESP200502041 | 2005-08-03 | ||
ES200502041A ES2277531B2 (es) | 2005-08-03 | 2005-08-03 | Procedimiento para la obtencion de clusteres cuanticos atomicos. |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2007017550A1 true WO2007017550A1 (es) | 2007-02-15 |
Family
ID=37727104
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/ES2006/070121 WO2007017550A1 (es) | 2005-08-03 | 2006-07-28 | Clústeres cuánticos atómicos estables, su procedimiento de obtención y uso de los mismos |
Country Status (7)
Country | Link |
---|---|
US (1) | US9421610B2 (es) |
EP (1) | EP1914196B1 (es) |
JP (3) | JP6186103B2 (es) |
KR (2) | KR101361266B1 (es) |
CN (1) | CN101248003A (es) |
ES (2) | ES2277531B2 (es) |
WO (1) | WO2007017550A1 (es) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009043958A1 (es) | 2007-10-05 | 2009-04-09 | Universidade De Santiago De Compostela | Uso de clústeres cuánticos atómicos (aqcs) como antimicrobianos y biocidas |
WO2011064430A2 (es) | 2009-11-25 | 2011-06-03 | Universidade De Santiago De Compostela | Tintas conductoras obtenidas por combinación de aqcs y nanopartículas metálicas |
WO2011113914A1 (en) | 2010-03-18 | 2011-09-22 | Universidade De Santiago De Compostela | Process for preparing anisotropic metal nanoparticles |
WO2013079669A1 (en) | 2011-12-02 | 2013-06-06 | Universidade De Santiago De Compostela | Photoconversion of light using metal supported atomic quantum clusters |
JP2014523932A (ja) * | 2011-06-15 | 2014-09-18 | ウニベルシダーデ デ サンティアゴ デ コンポステラ | 発光ナノシステム |
ES2529377A1 (es) * | 2013-06-07 | 2015-02-19 | Universidad Complutense De Madrid | Método para la producción de clústeres atómicos metálicos utilizando porfirinas y su inmovilización en la superficie de nanopartículas de óxidos metálicos y en sistemas núcleo@corteza. |
CN105903978A (zh) * | 2016-04-20 | 2016-08-31 | 中国科学院新疆理化技术研究所 | 一种硅烷稳定的荧光铜团簇的制备方法与用途 |
WO2019016391A1 (en) | 2017-07-21 | 2019-01-24 | Universidade De Santiago De Compostela | PROCESS FOR OXIDIZING ORGANOSUPRINED COMPOUNDS |
WO2019145409A1 (en) | 2018-01-24 | 2019-08-01 | Nanogap Sub Nm Powder, S.A. | Process for producing atomic quantum clusters |
WO2020094700A1 (en) | 2018-11-07 | 2020-05-14 | Universidade De Santiago De Compostela | Stable polymer composites |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2457572A1 (en) | 2010-11-05 | 2012-05-30 | Universidade De Santiago De Compostela | Use of atomic quantum clusters (aqcs) in the prevention of cell proliferative disorders, viral infections and autoimmune diseases |
US8999717B2 (en) | 2010-12-30 | 2015-04-07 | Indian Institute Of Technology Madras | Gold and silver quantum clusters in molecular containers and methods for their preparation and use |
PL2721414T3 (pl) | 2011-06-15 | 2018-01-31 | Fabrica Nac De Moneda Y Timbre Real Casa De La Moneda | Zastosowanie nanosystemów luminescencyjnych do uwierzytelniania zabezpieczanych dokumentów |
EP2743329A1 (en) | 2012-12-12 | 2014-06-18 | Fábrica Nacional de Moneda Y Timbre - Real Casa de la Moneda | Use of luminescent nanocompounds for authenticating security documents |
US9302322B2 (en) * | 2012-12-12 | 2016-04-05 | Nanogap Sub Nm Powder, S.A. | Luminescent nanocompounds |
EP2743695A1 (en) * | 2012-12-12 | 2014-06-18 | Nanogap Sub NM Powder, S.A. | Methods and reagents for the detection of biomolecules using luminescence |
CN103215032B (zh) * | 2013-04-24 | 2015-02-11 | 安徽大学 | 一种生物相容性强荧光金银混合团簇及其制备方法 |
CN105170997A (zh) * | 2015-10-13 | 2015-12-23 | 东南大学 | 双还原剂纳米金量子点的室温快速合成方法 |
JP6235764B1 (ja) * | 2015-12-28 | 2017-11-22 | トヨタ自動車株式会社 | クラスター担持触媒及びその製造方法 |
JP6226341B2 (ja) * | 2016-03-18 | 2017-11-08 | 公立大学法人首都大学東京 | 金クラスター触媒 |
CN105965028A (zh) * | 2016-05-20 | 2016-09-28 | 中国科学院新疆理化技术研究所 | 制备水溶性发光金属铂、金、银、铜团簇的方法及用途 |
JP6683571B2 (ja) * | 2016-08-10 | 2020-04-22 | トヨタ自動車株式会社 | 排ガス浄化触媒 |
JP2019199555A (ja) * | 2018-05-17 | 2019-11-21 | 中原大學 | 高い量子収量を有する複合蛍光金ナノクラスターおよびその製造方法 |
KR20210021306A (ko) * | 2018-06-12 | 2021-02-25 | 나노갭 서브-엔엠-파우더, 쏘시에다드 아노니마 | 정제된 원자 양자 클러스터를 제조하는 방법 |
MX2021003566A (es) * | 2018-09-26 | 2021-08-16 | Nanogap Sub Nm Powder S A | Usos terapeuticos de clusteres cuanticos atomicos. |
CN111496265B (zh) * | 2019-01-31 | 2022-09-27 | 中国科学院大连化学物理研究所 | 一种在溶液中稳定的还原态贵金属孤原子材料和制备方法 |
CN115283688B (zh) * | 2022-07-04 | 2024-03-26 | 电子科技大学 | 一种用固相动力学控制法制备金纳米团簇的方法 |
WO2024013181A1 (en) | 2022-07-12 | 2024-01-18 | Nanogap Sub-Nm-Powder, S.A. | METAL OXIDE SUPPORTED ATOMIC QUANTUM CLUSTERS (AQCs) CATALYSTS AS OXYGEN CARRIERS FOR CHEMICAL LOOPING PROCESSES |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020146742A1 (en) * | 1997-05-27 | 2002-10-10 | Wybourne Martin N. | Scaffold-organized metal, alloy, semiconductor and/or magnetic clusters and electronic devices made using such clusters |
WO2004003558A1 (en) | 2002-06-27 | 2004-01-08 | Georgia Tech Research Corporation | Nano-sized optical fluorescence labels and uses thereof |
WO2004014401A1 (de) * | 2002-08-02 | 2004-02-19 | Universität Duisburg-Essen | Metallcluster-nanoverbindungen zur behandlung von tumorerkrankungen |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0597865B1 (en) * | 1991-08-05 | 2001-07-25 | Mallinckrodt Inc. | Heavy metal clusters for use as imaging agents |
US5814370A (en) * | 1996-06-11 | 1998-09-29 | Sandia Corporation | Encapsulation of nanoclusters in dried gel materials via an inverse micelle/sol gel synthesis |
JPH11140436A (ja) * | 1997-11-07 | 1999-05-25 | Matsushita Electric Ind Co Ltd | 感熱発色材料およびその製造方法 |
DE19753464A1 (de) * | 1997-12-02 | 1999-06-10 | Basf Ag | Palladium-Cluster und ihre Verwendung als Katalysatoren |
JP3005683B1 (ja) | 1999-03-05 | 2000-01-31 | 大阪大学長 | 超微粒子の製造方法及び超微粒子 |
US6494932B1 (en) * | 2000-06-06 | 2002-12-17 | Birch Mountain Resources, Ltd. | Recovery of natural nanoclusters and the nanoclusters isolated thereby |
JP2002088406A (ja) * | 2000-09-12 | 2002-03-27 | Sekisui Chem Co Ltd | 金属コロイド溶液の製造方法及びその方法によって得られた金属コロイド溶液 |
US20020146748A1 (en) | 2001-01-22 | 2002-10-10 | L. David Sibley | Immunological detection of neosporosis using a recombinant antigen |
NZ513637A (en) * | 2001-08-20 | 2004-02-27 | Canterprise Ltd | Nanoscale electronic devices & fabrication methods |
JP2003342605A (ja) * | 2002-05-21 | 2003-12-03 | Akio Komatsu | 超微粒子、超微粒子結晶膜及び超微粒子結晶の製造方法 |
JP2004107728A (ja) * | 2002-09-18 | 2004-04-08 | Ebara Corp | 接合材料及び接合方法 |
JP2004292947A (ja) * | 2003-03-05 | 2004-10-21 | Fuji Photo Film Co Ltd | 磁性粒子の製造方法及び磁性粒子並びに磁気記録媒体 |
JP2004358583A (ja) * | 2003-06-03 | 2004-12-24 | Toyota Motor Corp | 白金ナノ構造体の製造方法 |
JP2005199267A (ja) * | 2003-12-15 | 2005-07-28 | Nippon Sheet Glass Co Ltd | 金属担持体の製造方法及び金属担持体 |
JPWO2005082561A1 (ja) * | 2004-02-27 | 2007-10-25 | 有限会社サンサーラコーポレーション | コロイダル金属 |
JP2005290498A (ja) * | 2004-04-01 | 2005-10-20 | Mitsubishi Materials Corp | 低温燒結性に優れた銀粘土用銀粉末およびこの銀粉末を含む銀粘土 |
DE102004061559A1 (de) * | 2004-12-21 | 2006-06-29 | Brueninghaus Hydromatik Gmbh | Hydraulischer Antrieb |
-
2005
- 2005-08-03 ES ES200502041A patent/ES2277531B2/es active Active
-
2006
- 2006-07-28 WO PCT/ES2006/070121 patent/WO2007017550A1/es active Application Filing
- 2006-07-28 US US11/997,859 patent/US9421610B2/en active Active
- 2006-07-28 CN CNA2006800287791A patent/CN101248003A/zh active Pending
- 2006-07-28 ES ES06778474T patent/ES2799308T3/es active Active
- 2006-07-28 KR KR1020087005221A patent/KR101361266B1/ko active IP Right Grant
- 2006-07-28 JP JP2008524535A patent/JP6186103B2/ja not_active Expired - Fee Related
- 2006-07-28 KR KR1020137030859A patent/KR101424943B1/ko active IP Right Grant
- 2006-07-28 EP EP06778474.4A patent/EP1914196B1/en active Active
-
2014
- 2014-10-30 JP JP2014220913A patent/JP6364319B2/ja active Active
-
2018
- 2018-03-13 JP JP2018045461A patent/JP7190818B2/ja active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020146742A1 (en) * | 1997-05-27 | 2002-10-10 | Wybourne Martin N. | Scaffold-organized metal, alloy, semiconductor and/or magnetic clusters and electronic devices made using such clusters |
WO2004003558A1 (en) | 2002-06-27 | 2004-01-08 | Georgia Tech Research Corporation | Nano-sized optical fluorescence labels and uses thereof |
WO2004014401A1 (de) * | 2002-08-02 | 2004-02-19 | Universität Duisburg-Essen | Metallcluster-nanoverbindungen zur behandlung von tumorerkrankungen |
Non-Patent Citations (24)
Title |
---|
"Metal Clusters", 1999, WILEY |
"Physics and Chemistry of Metal Cluster Compounds", 1994, KLUWER ACADEMI, article "Model Systems for Small Metal Particles, Series of Physical and Chemical Properties of Materials with Low-dimensional Structures" |
BARNETT, R.N. ET AL., EUR. PHYS. J. D, vol. 9, 1999, pages 95 |
BOYEN H-G. ET AL., SCIENCE, vol. 297, 2002, pages 1533 |
BRUST, M. ET AL., CHEM. SOC., CHEM. COMMUN., 1994, pages 801 |
CRESPO, P. ET AL., PHYS. REV. LETT., vol. 93, 2004, pages 087204 |
FOJTIK, A.; HENGLEIN, A.; JANA, E. J., PHYS. CHEM., vol. 96, 1992, pages 8203 |
G. SCHMID, ADV. ENG. MAT., vol. 3, 2001, pages 737 |
GARCIA-BASTIDA A.J. ET AL.: "Synthesis and structural characterization of Co immersed in Ag nanoparticles obtained by successive reactions in microemulsions", SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS, vol. 6, 1 July 2005 (2005-07-01), pages 411 - 419, XP005059090 * |
JIMENEZ, V.L. ET AL., ANAL. CHEM., vol. 75, 2003, pages 199 |
KREIBIG, U.; VOLLMER, M.: "Optical Properties of Metal Clusters", 1995, SPRINGER-VERLAG |
LEE, D. ET AL., J. AM. CHEM.SOC., vol. 125, 2003, pages 1182 |
LEE, H.M. ET AL., J.PHYS.CHEM. B, vol. 107, 2003, pages 9994 |
PETTY, J.T. ET AL., J. AM. CHEM. SOC., vol. 126, 2004, pages 5207 |
PEYSER, L.A. ET AL., SCIENCE, vol. 291, 2001, pages 103 |
PEYSER-CAPADONA, L. ET AL., PHYS.REV.LETT, vol. 94, 2005, pages 058301 |
RODRIGUEZ-SANCHEZ M.L. ET AL.: "Kinetics and Mechanism of the formation of Ag Nanoparticles by Electrochemical Techniques: A Plasmon and Cluster Time-Resolved Spectroscopic Study", JOURNAL OF PHYSICAL CHEMISTRY B, vol. 109, 27 January 2005 (2005-01-27), pages 1183 - 1191, XP003006094 * |
RODRIGUEZ-SANCHEZ, M. ET AL., J. PHYS. CHEM. B, vol. 109, 2005, pages 1183 |
SCHAAFF, T. G.; WHETTEN, R. L., J. PHYS. CHEM. B, vol. 104, 2000, pages 2630 |
SCHMID, G., CHEM. REV., vol. 92, 1992, pages 1709 |
See also references of EP1914196A4 |
SUGIMOTO, T: "Monodisperse Particles", 2001, ELSEVIER |
TANG Z. ET AL.: "A simple solution-phase reduction method for the synthesis of shape-controlled platinum nanoparticles", MATERIALS LETTERS, vol. 59, 4 May 2005 (2005-05-04), pages 1567 - 1570, XP004813253 * |
ZHENG, J.; ZHANG, C.; DICKSON R.M., PHYS.REV.LETT, vol. 93, 2004, pages 077402 |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9315380B2 (en) | 2007-10-05 | 2016-04-19 | Universidade De Santiago De Compostela | Use of atomic quantum cluster (AQC) as antimicrobial agents and biocides |
EP2206503A1 (en) * | 2007-10-05 | 2010-07-14 | Universidad De Santiago De Compostela | Use of atomic quantum clusters (aqc) as antimicrobial agents and biocides |
JP2011504459A (ja) * | 2007-10-05 | 2011-02-10 | ウニベルシダーデ デ サンティアゴ デ コンポステラ | 抗菌剤及び殺生物剤としての原子量子クラスター(aqc)の使用 |
EP2206503A4 (en) * | 2007-10-05 | 2011-09-07 | Univ Santiago Compostela | USE OF ATOMIC QUANTUM CLUSTERS (AQC) AS ANTIMICROBIOTICS AND BIOZIDES |
WO2009043958A1 (es) | 2007-10-05 | 2009-04-09 | Universidade De Santiago De Compostela | Uso de clústeres cuánticos atómicos (aqcs) como antimicrobianos y biocidas |
WO2011064430A2 (es) | 2009-11-25 | 2011-06-03 | Universidade De Santiago De Compostela | Tintas conductoras obtenidas por combinación de aqcs y nanopartículas metálicas |
WO2011113914A1 (en) | 2010-03-18 | 2011-09-22 | Universidade De Santiago De Compostela | Process for preparing anisotropic metal nanoparticles |
JP2014523932A (ja) * | 2011-06-15 | 2014-09-18 | ウニベルシダーデ デ サンティアゴ デ コンポステラ | 発光ナノシステム |
WO2013079669A1 (en) | 2011-12-02 | 2013-06-06 | Universidade De Santiago De Compostela | Photoconversion of light using metal supported atomic quantum clusters |
ES2529377A1 (es) * | 2013-06-07 | 2015-02-19 | Universidad Complutense De Madrid | Método para la producción de clústeres atómicos metálicos utilizando porfirinas y su inmovilización en la superficie de nanopartículas de óxidos metálicos y en sistemas núcleo@corteza. |
CN105903978A (zh) * | 2016-04-20 | 2016-08-31 | 中国科学院新疆理化技术研究所 | 一种硅烷稳定的荧光铜团簇的制备方法与用途 |
CN105903978B (zh) * | 2016-04-20 | 2017-12-15 | 中国科学院新疆理化技术研究所 | 一种硅烷稳定的荧光铜团簇的制备方法与用途 |
WO2019016391A1 (en) | 2017-07-21 | 2019-01-24 | Universidade De Santiago De Compostela | PROCESS FOR OXIDIZING ORGANOSUPRINED COMPOUNDS |
CN111065715A (zh) * | 2017-07-21 | 2020-04-24 | 圣地亚哥德孔波斯特拉大学 | 用于使有机硫化合物氧化的方法 |
US11149209B2 (en) | 2017-07-21 | 2021-10-19 | Universidade De Santiago De Compostela | Process for oxidation of organosulfur compounds |
WO2019145409A1 (en) | 2018-01-24 | 2019-08-01 | Nanogap Sub Nm Powder, S.A. | Process for producing atomic quantum clusters |
WO2020094700A1 (en) | 2018-11-07 | 2020-05-14 | Universidade De Santiago De Compostela | Stable polymer composites |
Also Published As
Publication number | Publication date |
---|---|
KR101424943B1 (ko) | 2014-08-01 |
KR101361266B1 (ko) | 2014-02-11 |
KR20080039467A (ko) | 2008-05-07 |
ES2277531A1 (es) | 2007-07-01 |
CN101248003A (zh) | 2008-08-20 |
US20090035852A1 (en) | 2009-02-05 |
KR20130140212A (ko) | 2013-12-23 |
JP7190818B2 (ja) | 2022-12-16 |
EP1914196B1 (en) | 2020-05-06 |
US9421610B2 (en) | 2016-08-23 |
JP6186103B2 (ja) | 2017-08-23 |
ES2277531B2 (es) | 2008-07-16 |
JP2009507996A (ja) | 2009-02-26 |
ES2799308T3 (es) | 2020-12-16 |
JP2018111885A (ja) | 2018-07-19 |
JP2015063759A (ja) | 2015-04-09 |
JP6364319B2 (ja) | 2018-07-25 |
EP1914196A4 (en) | 2010-12-29 |
EP1914196A1 (en) | 2008-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2799308T3 (es) | Clústeres cuánticos atómicos estables, su método de obtención y uso de los mismos | |
Sun et al. | Stimulus-responsive light-harvesting complexes based on the pillararene-induced co-assembly of β-carotene and chlorophyll | |
Bankura et al. | Synthesis, characterization and antimicrobial activity of dextran stabilized silver nanoparticles in aqueous medium | |
JP2018111885A5 (es) | ||
Zhao et al. | State of the art in gold nanoparticle synthesis | |
Selvakannan et al. | Synthesis of aqueous Au core− Ag shell nanoparticles using tyrosine as a pH-dependent reducing agent and assembling phase-transferred silver nanoparticles at the air− water interface | |
Egorova et al. | Biological effects of metal nanoparticles | |
Sreeprasad et al. | Noble metal nanoparticles | |
JP2015063759A5 (es) | ||
Gharib et al. | Protein-protected porous bimetallic AgPt nanoparticles with pH-switchable peroxidase/catalase-mimicking activity | |
JP2009507996A5 (es) | ||
Yu et al. | Guiding principles in the galvanic replacement reaction of an underpotentially deposited metal layer for site-selective deposition and shape and size control of satellite nanocrystals | |
Russo et al. | Time-and size-resolved plasmonic evolution with nm resolution of galvanic replacement reaction in AuAg nanoshells synthesis | |
Lv et al. | Surfactant design strategy for one-pot seedless synthesis of hollow mesoporous AuAg alloy nanospheres | |
Machado et al. | From complex inorganic oxides to Ag–Bi nanoalloy: synthesis by femtosecond laser irradiation | |
Choi et al. | Surface-controlled galvanic replacement for the development of Pt-Ag nanoplates with concave surface substructures | |
Cheng et al. | Controlling the nucleation and growth of Au on a-Se nanospheres to enhance their cellular uptake and cytotoxicity | |
Yoon et al. | Surface polarity-insensitive organosilicasome-based clustering of nanoparticles with intragap distance tunability | |
Bastús et al. | The reactivity of colloidal inorganic nanoparticles | |
Lee et al. | Synthesis of gold nanostructures using glycine as the reducing agent | |
Fuentes et al. | Synthesis of subnanometric metal nanoparticles | |
Patil | Fundamental aspects of regenerative cerium oxide nanoparticles and their applications in nanobiotechnology | |
Pacheco et al. | Gold compounds and their applications in medicine | |
Patarroyo | Exploring synthetic strategies for the production of complex inorganic nanoparticles | |
Egorova et al. | Methods of the Nanoparticle Preparation in Solutions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 200680028779.1 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008524535 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006778474 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1069/CHENP/2008 Country of ref document: IN Ref document number: 1020087005221 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2006778474 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11997859 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020137030859 Country of ref document: KR |